KORU Medical Systems (KRMD)
Nasdaq Market Open
KORU Medical Systems, Inc. is a medical technology company focused on subcutaneous drug delivery. The company develops, manufactures, and commercialises infusion products used to administer large-volume therapies beneath the skin, a method that can support treatment outside traditional hospital settings. Its products are used primarily in markets where patients require recurring therapy, including immune globulin administration and other specialty pharmaceutical applications.
The company’s portfolio centres on mechanical infusion systems and related consumables. Its best-known devices include the FREEDOM60 and FreedomEdge syringe drivers, which are designed to provide controlled delivery without relying on electronic pumps. KORU Medical also sells HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing, creating a recurring revenue stream tied to ongoing patient use. This mix of durable devices and disposable accessories is important to the company’s commercial model.
KORU Medical reports revenue through Domestic Core, International Core, and Pharma services and clinical trials. The Domestic Core business, which includes sales of syringe drivers, tubing, and needles in the United States, accounts for the largest share of revenue. International markets provide an additional channel, while the pharmaceutical services and clinical trial business links KORU’s delivery platform with drug developers evaluating subcutaneous administration for current or future therapies.
The company operates as a single segment and is closely tied to broader trends in home-based care, specialty pharmaceuticals, and patient-friendly drug delivery. Its competitive position rests on device reliability, ease of use, clinical adoption, and relationships with healthcare providers, distributors, and pharmaceutical companies.
Last updated
- Market Cap
- 180.06M
- P/E
- —
- P/FCF
- 1,004.26
- P/S
- 4.16
- Enterprise Value
- 171.46M
- Sector
- Health Care
- Industry
- Surgical and Medical Instruments and Apparatus
- Address
- 100 CORPORATE DRIVE, MAHWAH, NJ, 07430
Cirtec Medical Announces Appointment of New Chief Executive Officer
KORU Medical (KRMD) Forms New Deal on Subcutaneous Infusion
Silk Road Medical (SILK) Reports Q4 Loss, Tops Revenue Estimates
KORU Medical Systems Inc. (KRMD) Reports Q2 Loss, Tops Revenue Estimates
Masimo (MASI) Q2 Earnings Miss Estimates
Penumbra (PEN) Surpasses Q2 Earnings and Revenue Estimates
KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
Will KORU Medical Systems Inc. (KRMD) Report Negative Earnings Next Week? What You Should Know
KORU Medical Systems Inc. (KRMD) Reports Q4 Loss, Misses Revenue Estimates
Paragon 28, Inc. (FNA) Reports Q4 Loss, Tops Revenue Estimates
Penumbra (PEN) Q4 Earnings and Revenues Surpass Estimates
3 Best Breakout Stocks to Invest In Ahead of 2023
KORU Medical Systems Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates
DexCom (DXCM) Soars 7.3%: Is Further Upside Left in the Stock?
Repro Med Systems, Inc. (KRMD) Reports Q4 Loss, Tops Revenue Estimates
Veracyte (VCYT) Reports Q4 Loss, Tops Revenue Estimates
Silk Road Medical (SILK) Reports Q4 Loss, Tops Revenue Estimates
Analysts Estimate Repro Med Systems, Inc. (KRMD) to Report a Decline in Earnings: What to Look Out for
Repro Med Systems, Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates
Earnings Preview: Repro Med Systems, Inc. (KRMD) Q3 Earnings Expected to Decline
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 180.06M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 171.46M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 10.64
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 4.16
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -95.17
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 3.96
- EPS
- -0.05
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 1,004.26
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 251.99
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 179.29K
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -13.47%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -7.97%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.01
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 2.33
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.82
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.99
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 123.91K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 3.92
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 11.76M | 10.9M | 10.4M | 10.19M | 9.64M |
| Gross profit | 7.23M | 6.82M | 6.26M | 6.48M | 6.05M |
| Operating income | -864.92K | -547.1K | -867.68K | -312.66K | -1.25M |
| EBITDA | -667.39K | -367.93K | -663.2K | -103.17K | -1.03M |
| Net income | -807.08K | -486.86K | -777.97K | -206.87K | -1.17M |
| Basic EPS | -0.02 | -0.01 | -0.02 | — | -0.03 |
| Diluted EPS | -0.02 | -0.01 | -0.02 | — | -0.03 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 28.59M | 28.2M | 27.1M | 25.52M | 27.22M |
| Total liabilities | 11.67M | 11.15M | 10.64M | 8.99M | 10.87M |
| Total equity | 16.92M | 17.05M | 16.46M | 16.53M | 16.35M |
| Cash & equivalents | 8.77M | 8.87M | 8.46M | 8.05M | 8.74M |
| Current assets | 20.59M | 19.99M | 19.42M | 17.58M | 19M |
| Current liabilities | 8.85M | 8.19M | 7.83M | 6.05M | 7.8M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 14.66K | 1.09M | 65.46K | -460.34K | -237.47K |
| Investing cash flow | -89.89K | -421.66K | -52.48K | -28.81K | -446.84K |
| Financing cash flow | -29.22K | -264.91K | 396.33K | -191.96K | -160.81K |
| Change in cash | -104.44K | 408.19K | 409.3K | -681.12K | -845.11K |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 8-K — KORU Medical Systems, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — KORU Medical Systems, Inc. | View Filing | |
| edgar index | 4/A — KORU Medical Systems, Inc. | View Filing | |
| edgar index | 4 — KORU Medical Systems, Inc. | View Filing | |
| edgar index | 4 — KORU Medical Systems, Inc. | View Filing | |
| edgar index | 4 — KORU Medical Systems, Inc. | View Filing | |
| edgar index | 4 — KORU Medical Systems, Inc. | View Filing | |
| edgar index | 4 — KORU Medical Systems, Inc. | View Filing | |
| edgar index | 4 — KORU Medical Systems, Inc. | View Filing | |
| form 4 | Form 4 — Schiller Eric | View Filing | |
| form 4 | Form 4 — Tharby Linda M | View Filing | |
| form 4 | Form 4 — Tharby Linda M | View Filing | |
| edgar index | 144 — KORU Medical Systems, Inc. | View Filing | |
| form 4 | Form 4 — Adams Thomas Edward | View Filing | |
| form 4 | Form 4 — Adams Thomas Edward | View Filing | |
| form 4 | Form 4 — Adams Thomas Edward | View Filing | |
| form 4 | Form 4 — Adams Thomas Edward | View Filing | |
| form 4 | Form 4 — Pazdan Christopher | View Filing | |
| form 4 | Form 4 — Pazdan Christopher | View Filing | |
| form 4 | Form 4 — Pazdan Christopher | View Filing | |
| form 4 | Form 4 — Tharby Linda M | View Filing | |
| form 4 | Form 4 — Tharby Linda M | View Filing | |
| edgar index | 8-K — KORU Medical Systems, Inc. | View Filing | |
| edgar index | 10-Q — KORU Medical Systems, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G/A — KORU Medical Systems, Inc. | View Filing | |
| edgar index | DEF 14A — KORU Medical Systems, Inc. | View Filing | |
| edgar index | 4/A — KORU Medical Systems, Inc. | View Filing | |
| edgar index | 8-K — KORU Medical Systems, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — KORU Medical Systems, Inc. | View Filing | |
| edgar index | 4 — KORU Medical Systems, Inc. | View Filing | |
| edgar index | 4 — KORU Medical Systems, Inc. | View Filing | |
| edgar index | 4 — KORU Medical Systems, Inc. | View Filing | |
| edgar index | 4 — KORU Medical Systems, Inc. | View Filing | |
| edgar index | 4 — KORU Medical Systems, Inc. | View Filing | |
| form 4 | Form 4 — CASCELLA ROBERT | View Filing | |
| form 4 | Form 4 — FLETCHER R JOHN | View Filing | |
| form 4 | Form 4 — French Donna | View Filing | |
| form 4 | Form 4 — Matin Shahriar | View Filing | |
| form 4 | Form 4 — WHOLIHAN EDWARD | View Filing | |
| form 4 | Form 4 — Manko Joseph M. Jr. | View Filing | |
| form 4 | Form 4 — Manko Joseph M. Jr. | View Filing | |
| form 4 | Form 4 — Horton Capital Management, LLC | View Filing | |
| form 4 | Form 4 — Horton Capital Partners, LLC | View Filing | |
| form 4 | Form 4 — Horton Capital Partners, LLC | View Filing | |
| form 4 | Form 4 — Horton Capital Partners Fund, L.P. | View Filing | |
| form 4 | Form 4 — Horton Capital Partners Fund, L.P. | View Filing | |
| form 4 | Form 4 — Horton Capital Management, LLC | View Filing | |
| form 4 | Form 4 — Horton Capital Management, LLC | View Filing | |
| form 4 | Form 4 — Horton Capital Management, LLC | View Filing | |
| form 4 | Form 4 — Horton Capital Partners, LLC | View Filing | |
| form 4 | Form 4 — Horton Capital Partners Fund, L.P. | View Filing | |
| form 4 | Form 4 — Manko Joseph M. Jr. | View Filing | |
| form 4 | Form 4 — Horton Capital Partners, LLC | View Filing | |
| form 4 | Form 4 — Manko Joseph M. Jr. | View Filing | |
| form 4 | Form 4 — Horton Capital Partners Fund, L.P. | View Filing | |
| edgar index | 4 — KORU Medical Systems, Inc. | View Filing | |
| edgar index | 4 — KORU Medical Systems, Inc. | View Filing | |
| edgar index | 4 — KORU Medical Systems, Inc. | View Filing | |
| edgar index | 4 — KORU Medical Systems, Inc. | View Filing | |
| form 4 | Form 4 — Adams Thomas Edward | View Filing | |
| form 4 | Form 4 — Adams Thomas Edward | View Filing | |
| form 4 | Form 4 — Adams Thomas Edward | View Filing | |
| form 4 | Form 4 — Pazdan Christopher | View Filing | |
| form 4 | Form 4 — Pazdan Christopher | View Filing | |
| form 4 | Form 4 — Pazdan Christopher | View Filing | |
| form 4 | Form 4 — KALBERMATTEN ADAM R | View Filing | |
| form 4 | Form 4 — KALBERMATTEN ADAM R | View Filing | |
| form 4 | Form 4 — KALBERMATTEN ADAM R | View Filing | |
| edgar index | 8-K — KORU Medical Systems, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Tharby Linda M | View Filing | |
| form 4 | Form 4 — Tharby Linda M | View Filing |